Obesity 'hikes up' pancreatic cancer risk in women

Cancer Research UK

Obese women, who carry most of their excess weight around the stomach, are 70 per cent more likely to develop pancreatic cancer, according to a study published online in the British Journal of Cancer* today (Tuesday).

A team of researchers followed more than 138,000 postmenopausal women in America for over seven years to investigate the effects of obesity on pancreatic cancer as a part of the Women's Health Initiative - an ongoing study focussing on health problems experienced by postmenopausal women.

251 women in the study developed pancreatic cancer. Of these, 78 women had the highest waist-to-hip ratios. This is 70 per cent more than the 34 women with the lowest waist-to-hip ratios who went on to develop the disease - after adjusting for other potential risk factors including age and smoking status.

Lead author Dr Juhua Luo, based at the Karolinska Institute in Sweden, said: "We found that the risk of developing pancreatic cancer was significantly raised in obese postmenopausal women who carry most of their excess weight around the stomach. Obesity is a growing and largely preventable problem, so it's important that women are aware of this major increase in risk."

In 2004, around 7,400 cases of pancreatic cancer were diagnosed in the UK, and there are around 7,000 deaths from the disease each year. Around 3,800 women were diagnosed with pancreatic cancer in 2004 in the UK.

Pancreatic cancer is the UK's sixth most common cause of cancer death. Usually, the disease is diagnosed only once it has spread and is difficult to treat successfully. Only two or three per cent of people survive beyond five years after being diagnosed.

Before now, the most well established risk factors for pancreatic cancer were smoking and chronic pancreatitis - a rare inherited condition. Obesity was thought to play a role but the evidence pointed to a slightly stronger risk increase in men than women. This new research strengthens the evidence linking obesity to pancreatic cancer risk in women.

Research has also suggested that diabetes and abnormal insulin levels may play a role. The authors of this study believe that obesity could increase the risk of pancreatic cancer by affecting insulin levels.

Dr Luo continued: "We know that carrying a high proportion of abdominal fat is associated with increased levels of insulin, so we think this may cause the link between obesity and pancreatic cancer."

Dr Lesley Walker, director of cancer information at Cancer Research UK, said: "Pancreatic cancer is associated with particularly poor survival, so it's crucial that we learn more about how to prevent the disease.

"About a quarter of all cancer deaths are caused by unhealthy diets and obesity and it's important that people are aware of this risk."

ENDS

For media enquiries please contact the Cancer Research UK press office on 020 7061 8300 or, out-of-hours, the duty press officer on 07050 264 059.

Notes to Editor

*J Luo et al. Obesity and risk of pancreatic cancer among postmenopausal women: the Women’s Health Initiative (United States). British Journal of Cancer; advance online publication, July 15, 2008; doi: 10.1038/sj.bjc.6604487.

Being obese increases your risk of cancer of the womb, kidney, colon, gallbladder and oesophagus (foodpipe). Find out more about obesity and cancer on our healthy living website.

About pancreatic cancer

Pancreatic cancer is the eighth most common cancer in women, and the eleventh most common cancer in men in the UK. Pancreatic cancer develops from the cells within the pancreas, a gland located high up in the abdomen just behind the stomach. If pancreatic cancer is not treated, cancer cells can spread into nearby organs or lymph nodes, or, eventually, break away and spread to other parts of the body. For more information visit our website.

About the British Journal of Cancer (BJC)

The BJC's mission is to encourage communication of the very best cancer research from laboratories and clinics in all countries. Broad coverage, its editorial independence and consistent high standards have made BJC one of the world's premier general cancer journals. The BJC is owned by the charity Cancer Research UK.

About Cancer Research UK

  • Together with its partners and supporters, Cancer Research UK's vision is to beat cancer.
  • Cancer Research UK carries out world-class research to improve understanding of the disease and find out how to prevent, diagnose and treat different kinds of cancer.
  • Cancer Research UK ensures that its findings are used to improve the lives of all cancer patients.
  • Cancer Research UK helps people to understand cancer, the progress that is being made and the choices each person can make.
  • Cancer Research UK works in partnership with others to achieve the greatest impact in the global fight against cancer.
  • For further information about Cancer Research UK's work or to find out how to support the charity, please call 020 7009 8820 or visit our homepage.